DAILY STOCKMARKET REPORT 24 September 2010
Markets
London - UK stocks closed lower on Thursday, rallying late on with a turnaround on Wall Street after US existing home sales data, with firmer oils offset by weak drug makers and banks. The FTSE100 closed 4.83 points lower at 5547.08. Weak drug makers were the main drag on the index, with AstraZeneca and Shire down 1.1 and 0.8 percent, respectively, after Exane BNP Paribas cut ratings for both in a sector review. The broker upgraded its stance on GlaxoSmithkline but the stock still fell 1 percent on concerns that US and European regulators were set to pull its controversial diabetes drug Avandia off the market. Banks were also big blue chip fallers, with Lloyds Banking Group and Barclays off 1 and 0.3 percent respectively, as uncertainty over what steps governments will need to take to sustain the economic recovery weighed. Debate on the Bank of England’s Monetary Policy Committee is in a particularly aggressive and vigorous phase as policymakers struggle to assess the relative strength of upside and downside risks to inflation, Bank of England Chief Economist Spencer Dale said on Wednesday. Miners saw some support led by gold miner Randgold Resources up 1.1 percent, while Xstrata and Vedanta Resources both added 0.9 percent. Oil services stocks stood out after recent bid activity in the sector, supported by a bullish note from JPMorgan Cazenove. The broker said it sees signs of a broad and sustainable earnings upgrade rend for pan European oilfield services. Petrofac was the top blue chip riser, up 2.1 percent, while Amec gained 1.8 percent. Schroders was also a blue chip riser, up 17 percent helped by rumours of sector consolidation moves. Aberdeen Asset Management gained 2.4 percent on talk Japan’s Mitsubishi might be interested in upping its current 10 percent stake in the firm. Henderson Group fell 5 percent, after Citigroup cut its rating to hold.
Posted: September 24th, 2010 under Asset Management.
Comments: none
